Price
CHART BY
Frequently asked questions
What is Liquidia's market capitalization?
The market capitalization of Liquidia is $6.14B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Liquidia's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Liquidia is 50.30. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Liquidia?
Liquidia's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.364. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Liquidia's stock?
Currently, 9 analysts cover Liquidia's stock, with a consensus target price of $107.75. Analyst ratings provide insights into the stock's expected performance.
What is Liquidia's revenue over the trailing twelve months?
Over the trailing twelve months, Liquidia reported a revenue of $450.91M.
What is the EBITDA for Liquidia?
Liquidia's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $170.27M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Liquidia?
Liquidia has a free cash flow of $150.69M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Liquidia have, and what sector and industry does it belong to?
Liquidia employs approximately 216 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Liquidia's shares?
The free float of Liquidia is 77.38M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $6.14B
- EPS (TTM)
- $1.364
- Free Float
- 77.38M
- P/E ratio (TTM)
- 50.30
- Revenue (TTM)
- $450.91M
- EBITDA (TTM)
- $170.27M
- Free Cashflow (TTM)
- $150.69M
Pricing
- 1D span
- $67.42$69.45
- 52W span
- $21.15$93.58
Analyst Ratings
The price target is $107.75 and the stock is covered by 9 analysts.
Buy
6
Hold
3
Sell
0
Information
Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.
- Employees
- 216
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- LQDA
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet